Other Events ·
Nasdaq notifies company of regained compliance with the $1.00 minimum bid price requirement
TELATELA Bio, Inc.
TELA Bio, Inc. received a letter from The Nasdaq Stock Market LLC confirming that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1). The matter regarding non-compliance is now closed, and the company's common stock continues to be listed and traded on the exchange under the symbol "TELA". TELA Bio, Inc. operates in the medical device industry, developing wound care products.